Transgene SA (TRGNF)
0.80
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Transgene Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 21, 2026 | 0.1491 |
| September 18, 2026 | 0.1491 |
| September 17, 2026 | 0.1491 |
| September 16, 2026 | 0.1491 |
| September 15, 2026 | 0.1491 |
| September 14, 2026 | 0.1491 |
| September 11, 2026 | 0.1491 |
| September 10, 2026 | 0.1491 |
| September 09, 2026 | 0.1491 |
| September 08, 2026 | 0.1491 |
| September 04, 2026 | 0.1491 |
| September 03, 2026 | 0.1491 |
| September 02, 2026 | 0.1491 |
| September 01, 2026 | 0.1491 |
| August 31, 2026 | 0.1491 |
| August 28, 2026 | 0.1491 |
| August 27, 2026 | 0.1491 |
| August 26, 2026 | 0.1491 |
| August 25, 2026 | 0.1491 |
| August 24, 2026 | 0.1491 |
| August 21, 2026 | 0.1491 |
| August 20, 2026 | 0.1491 |
| August 19, 2026 | 0.1491 |
| August 18, 2026 | 0.1491 |
| August 17, 2026 | 0.1491 |
| Date | Value |
|---|---|
| August 14, 2026 | 0.1491 |
| August 13, 2026 | 0.1584 |
| August 12, 2026 | 0.1584 |
| August 11, 2026 | 0.1584 |
| August 10, 2026 | 0.1584 |
| August 07, 2026 | 0.1584 |
| August 06, 2026 | 0.1584 |
| August 05, 2026 | 0.1584 |
| August 04, 2026 | 0.1584 |
| August 03, 2026 | 0.1584 |
| July 31, 2026 | 0.1584 |
| July 30, 2026 | 0.1584 |
| July 29, 2026 | 0.1584 |
| July 28, 2026 | 0.1584 |
| July 27, 2026 | 0.1584 |
| July 24, 2026 | 0.1584 |
| July 23, 2026 | 0.1584 |
| July 22, 2026 | 0.1584 |
| July 21, 2026 | 0.1584 |
| July 20, 2026 | 0.1584 |
| July 17, 2026 | 0.1584 |
| July 16, 2026 | 0.1584 |
| July 15, 2026 | 0.1584 |
| July 14, 2026 | 0.1584 |
| July 13, 2026 | 0.1584 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cellectis SA | 3.090 |
| Compugen Ltd. | 2.274 |
| Evaxion AS | 2.686 |
| Halozyme Therapeutics, Inc. | 87.73 |
| AVITA Medical, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 475.77 |
| Price | 0.80 |
| Earnings Yield | -24.95% |
| Market Cap | 222.85M |